ProRx Pharma is moving to disrupt one of the fastest-growing corners of the medical wellness industry with the launch of an ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a new liquid formulation of thiotepa for the treatment of adults with adenocarcinoma of the ...
Several coronavirus disease 2019 (COVID-19) vaccines require multiple doses for long-lasting immunity. However, a new study published in the journal Biomacromolecules has developed a promising ...
Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery market reached U.S. $561 billion in 2021 ...
DANBURY, Conn., June 8, 2012-- Biodel Inc. and Aegis Therapeutics, LLC (Aegis) today announced a partnership providing Biodel an exclusive worldwide license to Aegis' proprietary ProTek® and ...
The product is supplied as a 90mg/mL multiple-dose vial for dilution. Ivra ™, a ready-to-dilute liquid formulation of melphalan, has been made available by Apotex. Ivra is an alkylating drug indicated ...
ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the availability of its innovative oral NAD+ formulation. This advancement introduces a new, convenient option ...
Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback